Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pharmacyclics
Pharmacyclics
The Pharmacyclics–AbbVie Merger: What Are the Details?
Yahoo/Market Realist
Sat, 03/28/15 - 10:28 am
Pharmacyclics
AbbVie
M&A
Could the Pharmacyclics–AbbVie Merger Get Competitive?
Yahoo/Market Realist
Tue, 03/24/15 - 03:13 pm
AbbVie
Pharmacyclics
M&A
JNJ
FDA panel recommends unblinding study after Imbruvica shows clear benefit
Yahoo/Reuters
Tue, 03/17/15 - 08:17 am
FDA
advisory panels
Imbruvica
Pharmacyclics
JNJ
AbbVie
Is The Biotechnology Bubble Turning Into Mania?
Forbes
Mon, 03/16/15 - 09:03 am
biotech
Gilead Sciences
Amgen
Regeneron
Puma Biotechnology
Isis Pharmaceuticals
Pharmacyclics
Intercept Pharmaceuticals
Just where does AbbVie expect to find $7B in Imbruvica sales?
Fierce Pharma Marketing
Tue, 03/10/15 - 01:21 pm
AbbVie
Imbruvica
M&A
Pharmacyclics
Why AbbVie Inc.'s $21 Billion Deal Had To Happen
Motley Fool
Mon, 03/9/15 - 08:39 am
AbbVie
M&A
Pharmacyclics
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
Fri, 03/6/15 - 03:09 pm
biotech
M&A
AbbVie
Pharmacyclics
Isis Pharmaceuticals
JNJ
Merck
NewLink Genetics
Roche
It's A Drug! It's A Pipeline! It's A New Blockbuster Model!
Forbes
Fri, 03/6/15 - 08:33 am
Pharmacyclics
AbbVie
M&A
Imbruvica
Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work
Bloomberg
Fri, 03/6/15 - 07:56 am
Richard Gonzalez
Pharma CEOs
AbbVie
Pharmacyclics
M&A
Inside the $21 Billion War for a Blockbuster Cancer Drug
Yahoo/Bloomberg
Fri, 03/6/15 - 07:53 am
AbbVie
Pharmacyclics
M&A
Imbruvica
JNJ
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
Fortune
Thu, 03/5/15 - 05:58 pm
AbbVie
Pharmacyclics
M&A
Surprised, stunned and supportive: Analysts assess AbbVie's $21B Pharmacyclics deal
Fierce Biotech
Thu, 03/5/15 - 05:33 pm
AbbVie
Pharmacyclics
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Motley Fool
Thu, 03/5/15 - 09:38 am
AbbVie
Pharmacyclics
M&A
Imbruvica
Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Forbes
Thu, 03/5/15 - 08:08 am
AbbVie
Pharmacyclics
M&A
J&J Said to Agree to Acquire Pharmacyclics for Cancer Drug
Bloomberg
Wed, 03/4/15 - 06:01 pm
JNJ
M&A
Pharmacyclics
Imbruvica
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
Motley Fool
Sun, 03/1/15 - 11:36 am
Gilead Sciences
Biogen Idec
Celgene
Pharmacyclics
Pharmacyclics mulls sale; J&J, Novartis interested - Bloomberg
Yahoo/Reuters
Wed, 02/25/15 - 04:27 pm
Pharmacyclics
JNJ
Novartis
M&A
J&J-Pharmacyclics drug shows potential in high-risk leukemia patients
Yahoo/Reuters
Tue, 02/17/15 - 12:46 pm
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Yahoo/Benzinga
Fri, 01/30/15 - 02:34 pm
Novartis
Celgene
Pharmacyclics
EXACT Sciences
Tesaro
Foundation Medicine
Bind Therapeutics
Kite Pharma
Celldex Therapeutics
FDA expands use of Imbruvica to treat rare form of blood cancer
Yahoo/Reuters
Thu, 01/29/15 - 07:19 pm
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »